Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters.
Engell-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM. Engell-Noerregaard L, et al. Among authors: thor straten p. Cancer Immunol Immunother. 2009 Jan;58(1):1-14. doi: 10.1007/s00262-008-0568-4. Epub 2008 Aug 22. Cancer Immunol Immunother. 2009. PMID: 18719915 Review.
Differential modulation by interferon gamma of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens.
Kirkin AF, thor Straten P, Zeuthen J. Kirkin AF, et al. Among authors: thor straten p. Cancer Immunol Immunother. 1996 May;42(4):203-12. doi: 10.1007/s002620050272. Cancer Immunol Immunother. 1996. PMID: 8665567
In a previous publication [Kirkin A. F., Petersen T. R., Olsen A. C., Li L., thor Straten P., Zeuthen J. (1995) Cancer Immunol Immunother 41:71] we have described the production of clones of cytotoxic T lymphocytes (CTL) against the highly immunogenic human m …
In a previous publication [Kirkin A. F., Petersen T. R., Olsen A. C., Li L., thor Straten P., Zeuthen J. (1995) Cancer …
In situ T cells in melanoma.
thor Straten P, Becker JC, Guldberg P, Zeuthen J. thor Straten P, et al. Cancer Immunol Immunother. 1999 Oct;48(7):386-95. doi: 10.1007/s002620050591. Cancer Immunol Immunother. 1999. PMID: 10501852 Review.
In situ cytokine therapy: redistribution of clonally expanded T cells.
thor Straten P, Guldberg P, Schrama D, Andersen MH, Moerch U, Seremet T, Siedel C, Reisfeld RA, Becker JC. thor Straten P, et al. Eur J Immunol. 2001 Jan;31(1):250-8. doi: 10.1002/1521-4141(200101)31:1<250::AID-IMMU250>3.0.CO;2-8. Eur J Immunol. 2001. PMID: 11265641 Free article.
Identification of novel survivin-derived CTL epitopes.
Reker S, Meier A, Holten-Andersen L, Svane IM, Becker JC, thor Straten P, Andersen MH. Reker S, et al. Among authors: thor straten p. Cancer Biol Ther. 2004 Feb;3(2):173-9. doi: 10.4161/cbt.3.2.611. Epub 2004 Feb 1. Cancer Biol Ther. 2004. PMID: 14726703
137 results